Results 81 to 90 of about 41,903 (261)
Chronic Intestinal Failure During the Neonatal Period Related to Height at Five Years of Age
Acta Paediatrica, EarlyView.ABSTRACT Aim To clarify if children with chronic intestinal failure during the neonatal period had a different height at 5 years of age compared to standardised Swedish growth charts. Methods This retrospective cohort study of children with chronic intestinal failure during the neonatal period in Gothenburg between 2004 and 2018.
Johanna Mårtenson +5 more
wiley +1 more source
BMC PediatricsPurpose To assess the incidence of bronchopulmonary dysplasia in preterm infants born at
Jiajing Ge +7 more
doaj +1 more source
Post-translational modifications and bronchopulmonary dysplasia
Frontiers in PediatricsBronchopulmonary dysplasia is a prevalent respiratory disorder posing a significant threat to the quality of life in premature infants. Its pathogenesis is intricate, and therapeutic options are limited. Besides genetic coding, protein post-translational
Kun Yang, Ting He, Xue Sun, Wenbin Dong
doaj +1 more source
Cardiopulmonary outcomes during stress in children and adolescents born prematurely [PDF]
, 2011 OBJECTIVE: To describe cardiopulmonary outcomes during physical stress in prematurely born children and adolescents. DATA SOURCES: Studies were obtained from PubMed, SciELO and Lilacs in Portuguese and in English from the last 20 years. The following key-
Davidson, Josy +3 more
core +3 more sources
Limited Evidence of Noradrenaline Use and Effectiveness in Preterm Neonates: A Systematic Review
Acta Paediatrica, EarlyView.ABSTRACT Aim The study aimed to analyse the effects and associated outcomes of noradrenaline in treating hypotension in preterm neonates. Methods We searched PubMed, Web of Science, and Scopus to August 2025 for randomised and observational studies on noradrenaline use in preterm neonates.
A. Vänskä, U. Sankilampi, I. Kuitunen
wiley +1 more source
MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
Педиатрическая фармакология, 2012 Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova +3 more
doaj +1 more source
Lung interstitial cells during alveolarization [PDF]
Korean Journal of Pediatrics, 2010 Recent progress in neonatal medicine has enabled survival of many extremely low-birth-weight infants. Prenatal steroids, surfactants, and non-invasive ventilation have helped reduce the incidence of the classical form of bronchopulmonary dysplasia ...
Chang Won Choi
doaj +1 more source
Long-term respiratory outcomes following preterm birth [PDF]
, 2018 Preterm birth interrupts the normal development of the respiratory system. Taken together with the lung injury that can occur antenatally such as from chorioamnionitis or postnatally by interventions such as mechanical ventilation and oxygen therapy,
Cousins, Michael +4 more
core +3 more sources
An Introduction to Bronchopulmonary Dysplasia
Clinics in Perinatology, 1992 Bronchopulmonary dysplasia (BPD) is both a significant clinical problem associated with neonatal intensive care and a sign of the success of that care. It can best be understood in the context of the historical continuum of improving survivability for prematurely born infants.
openaire +2 more sources
Acta Paediatrica, EarlyView.ABSTRACT Aim To describe changes in peripheral oxygen saturation (SpO2) and regional cerebral oxygenation (rcSO2) during less invasive surfactant administration (LISA) in a high‐level continuous positive airway pressure (CPAP) respiratory support delivery room protocol in very low birth weight infants (VLBW).
Jan Trieschmann +5 more
wiley +1 more source